Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Change in Account Payables (2016 - 2020)

Historic Change in Account Payables for Harvard Bioscience (HBIO) over the last 12 years, with Q4 2020 value amounting to -$154000.0.

  • Harvard Bioscience's Change in Account Payables fell 150000.0% to -$154000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $511000.0, marking a year-over-year increase of 12495.12%. This contributed to the annual value of $511000.0 for FY2020, which is 12495.12% up from last year.
  • Latest data reveals that Harvard Bioscience reported Change in Account Payables of -$154000.0 as of Q4 2020, which was down 150000.0% from -$585000.0 recorded in Q3 2020.
  • In the past 5 years, Harvard Bioscience's Change in Account Payables ranged from a high of $2.0 million in Q4 2018 and a low of -$2.7 million during Q1 2016
  • For the 5-year period, Harvard Bioscience's Change in Account Payables averaged around -$163750.0, with its median value being -$125000.0 (2017).
  • Over the last 5 years, Harvard Bioscience's Change in Account Payables had its largest YoY gain of 164166.67% in 2018, and its largest YoY loss of 259879.52% in 2018.
  • Over the past 5 years, Harvard Bioscience's Change in Account Payables (Quarter) stood at $372000.0 in 2016, then plummeted by 135.48% to -$132000.0 in 2017, then soared by 1641.67% to $2.0 million in 2018, then crashed by 99.46% to $11000.0 in 2019, then plummeted by 1500.0% to -$154000.0 in 2020.
  • Its last three reported values are -$154000.0 in Q4 2020, -$585000.0 for Q3 2020, and -$72000.0 during Q2 2020.